CCM
INVA icon

Consonance Capital Management’s Innoviva INVA Stock Holding History

Consonance Capital Management’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,002,675
Closed -$15.3M – 25
2018
Q3 		$15.3M Buy
+1,002,675
New +$14.4M 0.82% 28

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Consonance Capital Management's INVA Position: Q4 2018 in Review

Consonance Capital Management sold out of Innoviva (INVA) in Q4 2018, closing a stake of 1,002,675 shares — an estimated $15.3M sold.

Consonance Capital Management first reported a position in INVA in Q3 2018 and held it in 1 quarter. The position peaked at $15.3M in Q3 2018. 233 funds tracked by Wall St. Rank hold INVA as of Q4 2018.

  • Consonance Capital Management reported no remaining Innoviva position as of Q4 2018 after selling out during the quarter.
  • Consonance Capital Management sold 1,002,675 Innoviva shares in Q4 2018, an estimated $15.3M.
  • Consonance Capital Management first reported a position in Innoviva in Q3 2018 and held it in 1 quarter.
  • Consonance Capital Management's Innoviva position peaked at $15.3M in Q3 2018.
  • 233 funds tracked by Wall St. Rank held Innoviva as of Q4 2018.

Based on Consonance Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.